Prof. Gerritsen is medical oncologist at the Radboud Medical Center Nijmegen and is former Director of the Cancer Center Amsterdam. He has extensive expertise in translational research with a special interest in tumor-immunology and prostate cancer. Following his medical training at the University of Nijmegen, Prof. Gerritsen achieved his PhD in 1989 on bone marrow transplantation at the Medical School of the Erasmus University of Rotterdam, where after he worked in different positions at Memorial Sloan Kettering Cancer Center in New York, the University Hospital Utrecht, The Netherlands Cancer Institute / Antoni van Leeuwenhoek Hospital and the VU Medical Center.
Merus Named BioCapital Europe 2017 Company of the Year
Results of Cervical Cancer Study Sponsored by ISA Pharmaceuticals to Be Presented at ASCO-SITC